ArticleeLife2026

Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies.

Yi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.